LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Income Taxes Payable
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Income Taxes Payable of -$1.15 million for the 9-month period ending 2016-02-28, per its 10-Q filed 2016-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2016-03-30
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes payable for the quarter ending 2016-02-28 was -$448.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes payable for the quarter ending 2015-11-29 was $423.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes payable for the quarter ending 2015-08-30 was -$1.13M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes payable for fiscal 2015 was $1.23M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in income taxes payable for fiscal 2010 was $1.16M.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2016-02-28 | -$448.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | -$25.00K derived: sum of 2 quarters · filed 2016-03-30 | -$1.15M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $423.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | -$702.00K 10-Q · filed 2016-01-07 | ||
| 2015-08-30 | -$1.13M 10-Q · filed 2015-10-01 | |||
| 2015-05-31 | $1.23M 10-K · filed 2015-07-31 | |||
| 2010-05-30 | $1.16M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |